Leapfrog Bio is developing targeted therapies for cancers driven by genetic mutations that cannot be treated with conventional approaches. Our advanced pharmacogenomic approach yields novel insights into the biology of these cancers and simultaneously identifies small molecule compounds to effectively treat them. Our goal is to rapidly develop these compounds as genetically targeted therapies for cancer patients with high unmet medical needs.